MSN and breast carcinoma: Based on the results above, in which overexpression of MSN in ADR-resistant breast cancer cell lines established by long-term ADR treatment and MSN conferred resistance to ADR-based chemotherapy, we hypothesized that ADR might paradoxically lead to drug resistance through the activation of the MSN pathway.